GlassScriptPhysician profile
Sarah E Jian
NPI 1639571391
$1,912.05
in general payments reported to CMS, 2019-2025
16 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $521 · 2023: $494 · 2024: $114 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035 · Education: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.90 |
| Education | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $365.59 | 2021-2023 | Bronchitol |
| Abbvie INC. | $304.95 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $236.11 | 2025 | Zenpep |
| Insmed, INC. | $217.17 | 2023-2024 | Arikayce |
| Merck Sharp & Dohme LLC | $181.92 | 2022-2025 | Zerbaxa, Recarbrio |
| Glaxosmithkline, LLC. | $135.57 | 2023 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $118.74 | 2025 | Fasenra |
| Mylan Specialty L.P. | $107.17 | 2023 | Tobi Podhaler |
| Electromed, INC. | $50.58 | 2024-2025 | Smartvest |
| Alcresta Therapeutics, INC. | $49.36 | 2024 | Relizorb |
| Genentech USA, INC. | $34.28 | 2021-2022 | |
| Gilead Sciences, INC. | $32.06 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.68 | 2025 | |
| Tactile Systems Technology INC | $19.72 | 2023 | Flexitouch Plus, Entre Plus |
| Paratek Pharmaceuticals, INC. | $17.41 | 2025 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $15.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Jian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.